FBInvestor
Stocks / Apyx Medical Corporation
Institutional Ownership

Apyx Medical Corporation

CUSIP 03837C106COMAPYXQ1 2026

13D / 13G Filings
39
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
64
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

39 filings · latest Feb 13, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 13, 2026Nantahala Capital Management, LLC13G/A10.0%4.11MSEC
2Jan 20, 2026Royce &Amp; Associates LP13G/A6.0%2.44MSEC
3Feb 14, 2025Nantahala Capital Management, LLC13G10.0%3.49MSEC
4Oct 31, 2024Archon Capital Management LLC13G5.2%1.79MSEC
5Oct 15, 2024Royce & Associates LP13G/A7.5%2.58MSEC
6May 9, 2024Vizirgianakis Stavros G.13D/A5.0%1.75MSEC
7Apr 5, 2024Archon Capital Management LLC13D5.7%1.97MSEC
8Apr 1, 2024Vizirgianakis Stavros G.13D5.0%1.75MSEC
9Mar 25, 2024Hirschman Orin13G/ASEC
10Feb 14, 2024Pura Vida Investments, LLC13G/A0.2%80.0KSEC

29 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Apyx Medical Corporation.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →